Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global CT and PET Scanners market size was valued at USD 6,583 million in 2024. The market is projected to grow to USD 7,242 million by 2031, exhibiting a CAGR of 1.4% during the forecast period.
A Computed Tomography (CT) scanner, also known as a CAT scan, utilizes computer-processed X-ray images taken from multiple angles to generate detailed cross-sectional, or tomographic, images of the body. This sophisticated imaging modality allows clinicians to see inside a patient non-invasively. While Positron Emission Tomography (PET) scanners are nuclear medicine imaging systems that use radioactive tracers to visualize metabolic activity at a cellular level, providing crucial functional data often combined with CT's anatomical detail in hybrid PET-CT systems.
The market growth is largely driven by the rising global prevalence of chronic diseases like cancer and cardiovascular conditions, which require advanced diagnostic capabilities. However, the high capital investment and operational costs associated with these systems present a significant challenge, moderating growth. Key regions are showing varied dynamics; for instance, China dominates the market with an approximate 40% share, followed by North America and Europe which together hold around 45%. Furthermore, the market is highly consolidated, with the top five players including GE Healthcare, Siemens Healthineers, and Philips collectively commanding about 90% of the global market share, reflecting intense competition and high barriers to entry.
Rising Global Burden of Chronic Diseases
The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a primary driver for the CT and PET scanners market. These imaging modalities are essential for early detection, accurate diagnosis, staging, and treatment monitoring. The growing aging population, which is more susceptible to these diseases, further amplifies the demand for advanced diagnostic imaging.
Technological Advancements and Product Innovation
Continuous innovation is significantly propelling the market forward. The development of hybrid imaging systems, such as PET/CT and SPECT/CT, provides combined anatomical and functional data, improving diagnostic accuracy. Advancements like low-dose CT scans, digital PET detectors, and AI-powered image reconstruction and analysis software are enhancing image quality, reducing scan times, and minimizing radiation exposure for patients.
Hybrid PET/CT systems now account for over 80% of all PET scanner sales, underscoring the clinical preference for integrated diagnostic solutions.
Furthermore, the expansion of healthcare infrastructure in emerging economies and increased healthcare spending are making these advanced imaging technologies more accessible, driving market growth globally.
MARKET CHALLENGES
High Capital and Operational Costs
The acquisition, installation, and maintenance of CT and PET scanners involve substantial financial investment. A single PET/CT system can cost several million dollars, making it prohibitive for small clinics and hospitals in developing regions. Operational costs, including those for radiopharmaceuticals like Fluorodeoxyglucose (FDG) for PET scans and the need for specialized staff, add to the financial burden.
Other Challenges
Stringent Regulatory Hurdles and Reimbursement Policies
Obtaining regulatory approvals for new scanner models and imaging agents is a lengthy and costly process. Additionally, complex and varying reimbursement policies from government and private payers can limit patient access and hospital adoption rates for newer, often more expensive, technologies.
Shortage of Skilled Professionals
The effective operation and interpretation of scans from advanced CT and PET systems require highly trained personnel, including radiologists, radiographers, and medical physicists. A global shortage of these specialists can hinder the deployment and optimal utilization of this equipment.
Concerns Regarding Radiation Exposure
Despite technological improvements to lower doses, concerns about cumulative radiation exposure from diagnostic imaging procedures persist among patients and healthcare providers. This can lead to hesitation in referring patients for repeated or routine scans, potentially restraining market growth, particularly for CT systems.
Logistical Complexities of Radiopharmaceuticals
The PET scanner market is uniquely restrained by the short half-life of key radiopharmaceuticals, such as FDG, which decays rapidly. This necessitates an onsite cyclotron or a reliable, timely supply chain, creating significant logistical challenges and limiting the geographical spread of PET imaging centers.
Expansion into Emerging Markets
There is significant growth potential in emerging economies across Asia-Pacific, Latin America, and the Middle East. Rising disposable incomes, increasing healthcare expenditure, and government initiatives to modernize healthcare infrastructure present substantial opportunities for market expansion for both CT and PET scanner manufacturers.
Advancements in Molecular Imaging and Theranostics
The growing field of theranostics which combines targeted therapy and diagnostic imaging creates a promising avenue for PET scanners. The development of novel radiopharmaceuticals for specific cancers and neurological disorders is expected to drive the demand for advanced PET systems capable of precise molecular imaging.
Adoption of AI and Workflow Automation
Integration of artificial intelligence for automated image analysis, dose optimization, and workflow management presents a major opportunity. AI can enhance diagnostic accuracy, improve operational efficiency in imaging centers, and reduce radiologist burnout, making advanced imaging more scalable and accessible.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
CT Scanners represent the dominant product category within the market. These standalone systems are fundamental diagnostic tools in radiology departments globally due to their versatility and established clinical efficacy for visualizing detailed anatomical structures. Concurrently, the PET-CT Scanners segment is recognized for its specialized and high-value role in oncology, providing critical functional and metabolic data by combining positron emission tomography with computed tomography. This integration offers superior diagnostic confidence for disease staging and treatment monitoring, making it indispensable in advanced clinical settings despite its narrower application scope compared to standalone CT systems. |
| By Application |
|
Thoracic Cavity examinations constitute a leading application, driven by the high global incidence of pulmonary and cardiac conditions that require detailed cross-sectional imaging. Scans of the Head are also critically important for neurology and trauma, while cardiac imaging applications are growing with technological advances. The Abdominal and pelvic segment remains a cornerstone for diagnosing a wide range of gastrointestinal and urological disorders. The demand across these applications is sustained by the essential role of precise anatomical imaging in modern diagnostic pathways, ensuring steady utilization of these scanners in clinical practice. |
| By End User |
|
Hospitals are the primary end users, operating as the central hubs for complex medical imaging due to their high patient volume, emergency capabilities, and comprehensive clinical departments. Diagnostic Imaging Centers represent a significant segment, offering specialized and often more accessible outpatient services. Academic and Research Institutes utilize these scanners for both advanced clinical training and groundbreaking medical research, particularly in developing new imaging protocols and applications. The hospital segment's leadership is reinforced by the need for 24/7 availability and the ability to support a wide spectrum of medical and surgical specialties. |
| By Technology Level |
|
Low/Medium Slice Scanners form the backbone of the market, favored for routine diagnostic imaging due to their cost-effectiveness and reliability for common clinical tasks. The High-End and Premium Scanners segment, including advanced PET-CT systems, is characterized by cutting-edge capabilities such as higher resolution, faster scanning speeds, and lower radiation doses, catering to specialized clinical and research needs. The emerging Portable/Point-of-Care Scanners segment is gaining traction for its ability to provide critical imaging capabilities in intensive care units, emergency rooms, and remote locations, enhancing patient access and workflow efficiency. |
| By Purchase Model |
|
Direct Purchase/Capital Equipment remains the leading purchase model, particularly for large, well-funded hospitals and health systems that require full ownership and control over their imaging assets. Rental/Leasing Agreements offer financial flexibility, allowing smaller clinics and emerging markets to access advanced technology without significant upfront investment. The Pay-per-Scan/Managed Services model is an innovative approach gaining interest, where providers pay based on usage, reducing fixed costs and transferring maintenance responsibilities to the vendor. This model is particularly appealing for managing operational expenditures and accessing the latest technology upgrades without large capital outlays. |
A Market Dominated by a Handful of Global Giants
The global CT and PET scanners market is characterized by a high level of consolidation, with the top five players GE Healthcare, Siemens Healthineers, Philips, Canon Medical Systems (formerly Toshiba Medical Systems), and Shimadzu collectively commanding approximately 90% of the market share. This dominant position is reinforced by their extensive product portfolios, strong global distribution and service networks, and significant investment in research and development for advanced imaging technologies like spectral CT and digital PET-CT. These industry leaders compete primarily on technological innovation, offering systems with improved image resolution, faster scan times, lower radiation doses, and advanced AI-powered diagnostic software to enhance workflow efficiency and diagnostic accuracy.
Beyond the major global players, a number of other companies hold significant niches in the market. Manufacturers such as Hitachi and NeuroLogica cater to specific segments with specialized systems. Furthermore, regional players, particularly in Asia, are gaining traction. Companies like Neusoft Medical, Shenzhen Anke High-tech, and United Imaging from China are expanding their presence, offering cost-competitive solutions and capturing significant market share domestically, with China being the largest single market globally. These companies are increasingly focusing on technological advancements to compete on a broader scale, contributing to the dynamic nature of the competitive landscape.
List of Key CT and PET Scanners Companies ProfiledNeuroLogica (A Samsung Company)
Shenzhen Anke High-tech Co., Ltd.
Mediso Medical Imaging Systems
MIM Software Inc.
The global CT and PET Scanners market is on a path of consistent, modest growth, valued at US$ 6583 million in 2024 and projected to reach US$ 7242 million by 2031, reflecting a compound annual growth rate (CAGR) of 1.4%. This expansion is primarily fueled by the essential role of medical imaging in modern diagnostics and therapeutic planning across numerous medical disciplines. The technology, which uses computer-processed X-rays to generate detailed cross-sectional and three-dimensional images of the body's interior, remains a cornerstone of non-invasive diagnostic procedures. The growing global prevalence of chronic diseases requiring precise imaging for diagnosis and monitoring, such as cancer and cardiovascular conditions, underpins the sustained demand for these advanced scanners. The market's stability is attributed to the continuous need for equipment upgrades and replacements in established healthcare systems worldwide.
Other TrendsDominance of Established Players and Product Segments
The competitive landscape of the CT and PET Scanners market is highly concentrated, with the top five global players GE Healthcare, Siemens Healthcare, Philips, Toshiba, and Shimadzu collectively holding approximately 90% of the market share. This consolidation indicates high barriers to entry and the significant influence these companies have on technological advancements and pricing. In terms of product segmentation, CT Scanners (excluding PET-CT combinations) represent the largest product category, commanding about 90% of the market. The largest application segment is imaging of the Thoracic Cavity, followed by the Head, Heart, and Abdominal and pelvic regions, highlighting the critical role these scanners play in diagnosing conditions affecting major organs.
Geographically, the market demonstrates clear regional concentrations. China has emerged as the largest single market, accounting for roughly 40% of the global share. This is followed by the combined markets of North America and Europe, which together hold about 45% of the market. This distribution reflects the interplay between a massive, rapidly developing healthcare infrastructure in China and the mature, technologically advanced medical systems in North America and Europe. The growth potential in the Asia-Pacific region, outside of China, presents a significant opportunity for market expansion, driven by increasing healthcare expenditure and modernization of medical facilities in countries like India, Japan, and South Korea.
Regional Analysis: CT and PET Scanners MarketEurope
Europe represents a mature and highly sophisticated market for CT and PET scanners, characterized by strong regulatory standards and universal healthcare systems in many countries. Adoption is driven by a focus on evidence-based medicine and high-quality diagnostic standards. However, market dynamics vary between Western and Eastern Europe. Western European nations, such as Germany, France, and the UK, exhibit high penetration rates and a focus on replacing aging equipment with more advanced, efficient models. In contrast, Eastern Europe shows significant growth potential as healthcare infrastructure is modernized and investment increases. The region faces challenges related to stringent pricing pressures and budget constraints within public health systems, which can slow the adoption rate of the very latest, most expensive technologies compared to North America.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for CT and PET scanners, propelled by its large population, rising disposable incomes, and increasing government initiatives to improve healthcare access. Countries like China, Japan, and India are major drivers. Japan has a mature market with a high density of scanners and a strong domestic manufacturing base. China's market is expanding rapidly due to massive healthcare infrastructure development and growing diagnosis rates. India presents immense potential, with growth concentrated in urban private hospitals, though access in rural areas remains a challenge. The overall region benefits from less stringent regulatory pathways in some countries, allowing for quicker market entry, and a growing middle class willing to pay for advanced diagnostic services.
South America
The South American market for CT and PET scanners is emerging, with growth heavily influenced by economic stability and government healthcare spending. Brazil is the largest market in the region, but adoption is often concentrated in major urban centers and private healthcare networks. Public healthcare systems face budgetary limitations, which can restrict widespread access to advanced imaging. Market growth is driven by an increasing burden of chronic diseases and a gradual modernization of medical infrastructure. However, the market remains susceptible to economic volatility and political changes that impact public investment in health technology, making growth more uneven compared to other regions.
Middle East & Africa
This region displays a highly variable market landscape. Wealthy Gulf Cooperation Council (GCC) countries, such as Saudi Arabia and the UAE, represent high-growth pockets with significant government investment in building state-of-the-art medical cities and hospitals, leading to strong demand for premium imaging equipment. In contrast, many parts of Africa face significant challenges, including limited healthcare infrastructure, funding shortages, and a scarcity of trained personnel, resulting in very low penetration of CT and PET scanners. The market is thus bifurcated, with advanced systems concentrated in a few affluent areas, while the broader region presents long-term growth potential dependent on economic development and international aid for healthcare improvement.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252031. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type (CT Scanners, PET-CT Scanners)
By application (Head, Thoracic Cavity, Heart, Abdominal and Pelvic, Extremities)
By end-user (Hospitals, Diagnostic Centers)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation and digitalization in medical imaging
AI integration in diagnostic imaging
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Diagnostic imaging centers
Investors and venture capitalists
Policy makers and regulatory bodies
-> Global CT and PET Scanners market was valued at USD 6,583 million in 2024 and is expected to reach USD 7,242 million by 2031, exhibiting a CAGR of 1.4%.
-> Key players include GE Healthcare, Siemens Healthcare, Philips, Toshiba, and Shimadzu, with top five players holding ~90% market share.
-> Key growth drivers include rising prevalence of chronic diseases and increasing demand for advanced diagnostic imaging.
-> China is the largest market with ~40% share, followed by North America and Europe with ~45% combined share.
-> CT Scanners account for ~90% of the market, with PET-CT Scanners making up the remainder.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates